Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Trevi Therapeutics, Inc. (TRVI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/14/2023 4 Delfini Lisa (CFO) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Sold 682 shares @ $2.36, valued at $1.6k
Exercised 2,292 options to buy @ $0.511, valued at $1.2k
07/12/2023 4 Delfini Lisa (CFO) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Sold 687 shares @ $2.34, valued at $1.6k
Exercised 2,292 options to buy @ $0.511, valued at $1.2k
06/30/2023 4 Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.27, valued at $68.1k
06/30/2023 4 Cassella James V (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.27, valued at $68.1k
06/30/2023 4 Heffernan Michael Thomas (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.27, valued at $68.1k
06/30/2023 4 Meeker David P (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.27, valued at $68.1k
06/30/2023 4 Colangelo Dominick (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.27, valued at $68.1k
06/30/2023 4 VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.27, valued at $68.1k
03/15/2023 4 Delfini Lisa (CFO) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Sold 892 shares @ $1.7532, valued at $1.6k
Exercised 2,291 options to buy @ $0.511, valued at $1.2k
03/08/2023 4 Simon Farrell (Chief Commercial Officer) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Exercised 18,750 options to buy @ $0.511, valued at $9.6k
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/19/2022 4 SCIASCIA THOMAS (Chief Medical Officer) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 7,500 options to buy @ $3.21, valued at $24.1k
09/19/2022 4 GOOD JENNIFER L (President & CEO) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 32,000 options to buy @ $3.21, valued at $102.7k
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $2.27, valued at $45.4k
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Colangelo Dominick (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $2.27, valued at $45.4k
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2022 4 TPG GP A, LLC (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Sold 600 shares @ $2.7, valued at $1.6k
05/02/2022 4 TPG GP A, LLC (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Sold 7,271 shares @ $2.7699, valued at $20.1k
Sold 16,163 shares @ $2.7461, valued at $44.4k
04/13/2022 4 Mathers Edward T (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 948,948 shares @ $1.9, valued at $1.8M
Granted 3,000,000 options to buy @ $0.001, valued at $3k
04/13/2022 4 Walker Paul Edward (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Bought 2,631,578 shares @ $1.9, valued at $5M
Bought 948,948 shares @ $1.9, valued at $1.8M
Bought 3,000,000 options to buy @ $0.001, valued at $3k
04/13/2022 4 Sonsini Peter W. (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Bought 2,631,578 shares @ $1.9, valued at $5M
Bought 948,948 shares @ $1.9, valued at $1.8M
Bought 3,000,000 options to buy @ $0.001, valued at $3k
04/13/2022 4 SANDELL SCOTT D (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Bought 2,631,578 shares @ $1.9, valued at $5M
Bought 948,948 shares @ $1.9, valued at $1.8M
Bought 3,000,000 options to buy @ $0.001, valued at $3k
04/13/2022 4 Makhzoumi Mohamad (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Bought 2,631,578 shares @ $1.9, valued at $5M
Bought 948,948 shares @ $1.9, valued at $1.8M
Bought 3,000,000 options to buy @ $0.001, valued at $3k
04/13/2022 4 Florence Anthony A. Jr. (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Bought 2,631,578 shares @ $1.9, valued at $5M
Bought 948,948 shares @ $1.9, valued at $1.8M
Bought 3,000,000 options to buy @ $0.001, valued at $3k
04/13/2022 4 Chang Carmen (10% Owner) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Bought 2,631,578 shares @ $1.9, valued at $5M
Bought 948,948 shares @ $1.9, valued at $1.8M
Bought 3,000,000 options to buy @ $0.001, valued at $3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy